Additionally, PEC demonstrated superior effects in regulating aquaporin gene expression, activating SCF/C-kit and Nrf2/HO-1 signaling pathways, and reducing ICC apoptosis. The gene discussed is KITLG; the disease is intrahepatic cholangiocarcinoma.